New empirical evidence on the long-term effects of oestrogen treatment for tall adolescent girls has shown that the intended psychosocial benefit of the treatment may not have been realised. This paper describes recent trends in the prevalence of the treatment and the results of a large Australian cohort study evaluating girls assessed between 1959 and 1993 for excessive growth. The paper concludes that oestrogen treatment to prevent extreme tallness should belong to the past, not to the future.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- Medicine treatment of glaucoma in Australia 2012–2019: prevalence, incidence and persistence
- Depression, depressive symptoms and treatments in women who have recently given birth: UK cohort study
- How tall is too tall? On the ethics of oestrogen treatment for tall girls
- The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003
- Does retirement reduce the risk of mental disorders? A national registry-linkage study of treatment for mental disorders before and after retirement of 245 082 Danish residents
- Prevalence of treatment with glaucoma medication in Scotland, 2010–2017
- Pharmaceutical treatment of symptomatic vertebral fractures in primary care
- Trends in the prevalence of respiratory symptoms and treatment in Dutch children over a 12 year period: results of the fourth consecutive survey
- Changes in self-reported sexually transmitted infections and symptoms among married couples in India from 2006 to 2016: a repeated cross-sectional multivariate analysis from nationally representative data
- Oestrogen treatment of constitutional tall stature: a risk-benefit ratio